Omicron boosters are the future of COVID vaccines in the U.S.
Popular Science, September 5, 2022
Dr. Pei-Yong Shi, an expert in vaccine development and virology at the University of Texas Medical Branch, commented on shots that Moderna and Pfizer made for both the Beta and Delta variants that went through human trials. “The companies have tried multiple modified sequences before,” he said. “I’m totally in support of this recommendation of bivalent boosters,” Shi adds. “I think we can always say we want more clinical data, but if that’s the case, we’re always playing the catch-up game.”